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Tuberculosis (TB) is a common and often deadly infectious disease caused by various strains of 
mycobacteria, usually Mycobacterium tuberculosis in humans. Because of population growth, the 
absolute number of new cases is still increasing. Multi-drug-resistant tuberculosis (MDR-TB) is 
defined as resistance to the two most effective first-line TB drugs and is a public health issue in 
many developing countries, as treatment is longer and requires more expensive drugs. Recently, a 
new experimental diarylquinoline anti-tuberculosis drug was discovered at Janssen Pharmaceutica, 
referred to as TMC207 and shown in Fig. 1. Before TMC207 can be made commercially available, 
one of the necessary investigations is a thorough pharmacokinetic study to investigate its 
absorption, distribution, metabolism and excretion (ADME) [1]. 
In order to investigate the distribution of TMC207, the 14C labelled compound TMC207 was 
administered to rat samples which were then killed by inhalation of anaesthetic after 1/4/8h 
respectively. Animals were immediately frozen (hexane/CO2; -78°C) and embedded in 
carboxymethyl cellulose (CMC). Subsequently, thin sections at a position of interest are obtained 
by microtomy which are freeze-dried afterwards. Finally, the thin sections are exposed to phosphor-
imaging plates (IP’s), after which the tissue concentrations are analyzed as shown in Fig. 2 and 
quantified. 
Figure 1: TMC207.  Figure 2: Radioluminography (RLG) of rat thin section. 
Interestingly, TMC207 contains a single Br atom (Fig. 1), potentially allowing its trace level 
imaging by means of synchrotron radiation micro X-ray Fluorescence (SR micro-XRF) without 
using radiolabelled compounds. Therefore, the previously described rat thin sections were subjected 
to micro-XRF analysis at the hard X-ray microprobe Beamline L. A multilayer monochromator was 
used to obtain an excitation energy of 15 keV, optimally exciting the Br-K edge. The thin sections 
were mounted on a cardboard frame which was then attached to a high-speed motor stage with a 
large travel range as shown in Fig. 3. A polycapillary (PC) half lens (XOS, USA) at non-optimal 
working distance delivered a beam size of 90 µm (V) x 300 µm (H) FWHM possessing a higher 
flux density compared to a collimated beam of these dimensions, improving the scanning time for 
the same detection limit considerably. The rat thin sections were scanned in a vertical continuous 
scanning mode (500 µm step size, LT=1.5s/point), compensating for the smaller beam size in the 
vertical dimension. A Silicon Drift Detector (SDD, VORTEX) with 80 mm² active area was used 
for collecting the XRF point spectra which were subsequently processed with the AXIL software. 
An estimation of the detection limits was performed using NIST SRM 1577B (Bovine Liver). 
Elemental distributions for Cl, K, Fe and Zn respectively within an entire rat thin section are shown 
in Fig. 4. Corresponding detection limits for these elements (LT=1.5s) were estimated to be 130, 
25, 0.9 and 0.4 ppm respectively. 
Figure 3: SR micro-XRF scanning set-up.   Figure 4: 2D micro-XRF results on rat thin sections.  
Due to 1) the low concentration of Br in the sample (~0.3 ppm) 2) the high concentration of Br in 
the CMC support and 3) the higher detection limit (~1 ppm) corresponding to the scanning time of 
1.5s/point, an elemental distribution of high quality of this element could unfortunately not be 
obtained. However, several line scans (10 points, LT=50s, range=2mm) were performed upon 
tissues of interest (lung, liver, exposed/upper stomach, adrenal glad). This resulted in XRF 
sumspectra of the different tissues as shown in Fig. 5. Moreover, a better detection limit for Br was 
obtained (MDL ~ 55 ppb), which resulted in a clearly distinguishable Br content between the 
different tissues. Principal component analysis was performed on the normalised sum spectra of 
which the results are shown in Fig. 6. A clear decreasing trend of the Br concentration can be 
observed from the stomach (point 3/5/6) towards the lung tissue (point 1) and the liver tissue 
/adrenal gland (point 2/4) respectively. These results are perfectly matching with results obtained 
from 14C labelling followed by radioluminography (Fig. 2) and laser ablation inductively coupled 
plasma mass spectrometry (LA-ICPMS), indicating the interesting alternative of the SR based 
micro-XRF technique for spatially resolved pharmacokinetic studies of heteroatom containing 
drugs in an essentially non-destructive manner. 
Figure 5: Sum spectra of XRF line scans.  Figure 6: PCA analysis of XRF sum spectra. 
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